Showing 1 - 13 results of 13 for search 'Jennifer A. Rymer', query time: 0.04s Refine Results
  1. 1
    The Current State of Transradial Access: A Perspective on Transradial Outcomes, Learning Curves, and Same-Day Discharge

    The Current State of Transradial Access: A Perspective on Transradial Outcomes, Learning Curves, and Same-Day Discharge by Sunil V. Rao, Jennifer A. Rymer

    Published 2018-06-01
    Get full text
    Article
  2. 2
    Failure to Launch

    Failure to Launch by Jennifer A. Rymer, MD, MBA, L. Kristin Newby, MD, MHS

    Published 2017-08-01
    Get full text
    Article
  3. 3
    Differences in Preferences Between Clinicians and Patients for the Use and Dosing of Direct Oral Anticoagulants for Atrial Fibrillation

    Differences in Preferences Between Clinicians and Patients for the Use and Dosing of Direct Oral Anticoagulants for Atrial Fibrillation by Jennifer A. Rymer, Laura Webb, Debbe McCall, Mellanie T. Hills, Tracy Y. Wang

    Published 2021-06-01
    Get full text
    Article
  4. 4
    Difference in Medication Adherence Between Patients Prescribed a 30‐Day Versus 90‐Day Supply After Acute Myocardial Infarction

    Difference in Medication Adherence Between Patients Prescribed a 30‐Day Versus 90‐Day Supply After Acute Myocardial Infarction by Jennifer A. Rymer, Eileen Fonseca, Durgesh D. Bhandary, Deepa Kumar, Naeem D. Khan, Tracy Y. Wang

    Published 2021-01-01
    Get full text
    Article
  5. 5
    Readmissions After Acute Myocardial Infarction: How Often Do Patients Return to the Discharging Hospital?

    Readmissions After Acute Myocardial Infarction: How Often Do Patients Return to the Discharging Hospital? by Jennifer A. Rymer, Anita Y. Chen, Laine Thomas, Gregg C. Fonarow, Eric D. Peterson, Tracy Y. Wang

    Published 2019-10-01
    Get full text
    Article
  6. 6
    Safety of Dual‐Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease

    Safety of Dual‐Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease by Jennifer A. Rymer, Lisa A. Kaltenbach, Jacob A. Doll, John C. Messenger, Eric D. Peterson, Tracy Y. Wang

    Published 2019-05-01
    Get full text
    Article
  7. 7
    Challenge in Predicting Persistence to P2Y12 Inhibitors: A Perspective From the ARTEMIS Trial

    Challenge in Predicting Persistence to P2Y12 Inhibitors: A Perspective From the ARTEMIS Trial by Jennifer A. Rymer, Zachary K. Wegermann, Lisa A. Kaltenbach, Laura E. Webb, Eric D. Peterson, Tracy Y. Wang

    Published 2023-06-01
    Get full text
    Article
  8. 8
    Advanced Practice Provider Versus Physician‐Only Outpatient Follow‐Up After Acute Myocardial Infarction

    Advanced Practice Provider Versus Physician‐Only Outpatient Follow‐Up After Acute Myocardial Infarction by Jennifer A. Rymer, Anita Y. Chen, Laine Thomas, Judith Stafford, Jonathan R. Enriquez, Abhinav Goyal, Eric D. Peterson, Tracy Y. Wang

    Published 2018-09-01
    Get full text
    Article
  9. 9
    Use of Low‐Density Lipoprotein–Lowering Therapies Before and After PCSK9 Inhibitor Initiation

    Use of Low‐Density Lipoprotein–Lowering Therapies Before and After PCSK9 Inhibitor Initiation by Jennifer A. Rymer, Katherine E. Mues, Keri L. Monda, Emily W. Bratton, Heidi S. Wirtz, Ted Okerson, Robert A. Overman, M. Alan Brookhart, Paul Muntner, Tracy Y. Wang

    Published 2020-05-01
    Get full text
    Article
  10. 10
    Does the Effectiveness of a Medicine Copay Voucher Vary by Baseline Medication Out‐Of‐Pocket Expenses? Insights From ARTEMIS

    Does the Effectiveness of a Medicine Copay Voucher Vary by Baseline Medication Out‐Of‐Pocket Expenses? Insights From ARTEMIS by Jennifer A. Rymer, Lisa A. Kaltenbach, Eric D. Peterson, David J. Cohen, Gregg C. Fonarow, Niteesh K. Choudhry, Timothy D. Henry, Christopher P. Cannon, Tracy Y. Wang

    Published 2022-10-01
    Get full text
    Article
  11. 11
    Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial

    Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagre... by Jennifer A. Rymer, Hillary Mulder, Kim G. Smolderen, William R. Hiatt, Michael S. Conte, Jeffrey S. Berger, Lars Norgren, Kenneth W. Mahaffey, Iris Baumgartner, F. Gerry Fowkes, Brian G. Katona, Frank Rockhold, W. Schuyler Jones, Manesh R. Patel

    Published 2020-10-01
    Get full text
    Article
  12. 12
    Lawn Mower Versus Left Ventricular Assist Device

    Lawn Mower Versus Left Ventricular Assist Device by Vishal N. Rao, MD, MPH, Marat Fudim, MD, MHS, Andrew Griffin, MD, Jennifer A. Rymer, MD, MBA, W. Schuyler Jones, MD, Lynne M.H. Koweek, MD, Tony P. Smith, MD, Daniele Marin, MD, Adam D. DeVore, MD, MHS

    Published 2020-03-01
    Get full text
    Article
  13. 13
    Cangrelor Use Patterns and Transition to Oral P2Y12 Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO Registry

    Cangrelor Use Patterns and Transition to Oral P2Y12 Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO Registry by Jennifer A. Rymer, Deepak L. Bhatt, Dominick J. Angiolillo, Miguel Diaz, Kirk N. Garratt, Ron Waksman, Laura Edwards, Gudaye Tasissa, Khalid Salahuddin, Hijrah El‐Sabae, Carmen Dell’Anna, Linda Davidson‐Ray, Jeffrey B. Washam, E. Magnus Ohman, Tracy Y. Wang

    Published 2022-06-01
    Get full text
    Article

Search Tools: